![](/img/cover-not-exists.png)
Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
Petrylak, Daniel P, Vogelzang, Nicholas J, Budnik, Nikolay, Wiechno, Pawel Jan, Sternberg, Cora N, Doner, Kevin, Bellmunt, Joaquim, Burke, John M, de Olza, Maria Ochoa, Choudhury, Ananya, Gschwend, JuVolume:
16
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)70025-2
Date:
April, 2015
File:
PDF, 308 KB
english, 2015